Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2024

Open Access 01-12-2024 | Insulins | Research

Correlation between insulin resistance and the rate of neutrophils-lymphocytes, monocytes-lymphocytes, platelets-lymphocytes in type 2 diabetic patients

Authors: Yuanyuan Zhang, Huaizhen Liu

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

Insulin resistance (IR) was a prominent feature commonly observed in individuals with type 2 diabetes mellitus (T2DM). T2DM Individuals often exhibited a concomitant presence of low-grade chronic inflammation. In this study conducted retrospectively, the aim was to investigate the connection between neutrophils-lymphocytes rate (NLR), monocytes-lymphocytes rate (MLR), platelets-lymphocytes rate (PLR) and IR, specifically among individuals with T2DM.

Method

This study encompassed a cohort of 405 individuals diagnosed with T2DM, comprising cases from January 2021 to November 2022. On the basis of whether there was IR or not, these sufferers were categorized into two cohorts, namely T2DM with IR group (292 cases) and T2DM without IR group (113 cases), as determined by a homeostasis model assessment-IR (HOMA-IR) value exceeding 2.0.

Results

The findings of this study demonstrated compelling evidence of distinct biomarker profiles between individuals with T2DM who had IR and those without IR. Specifically, the IR individuals displayed notably raise NLR, MLR, PLR, C reactive protein (CRP) and serum amyloid A (SAA). Additionally, there was a noticeable decrease in superoxide dismutase (SOD) levels. Furthermore, IR was negatively correlated with SOD values, while positive associations were found between IR and NLR, CRP, and SAA levels (p < 0.05). Moreover, a rise in NLR and PLR levels demonstrated an identical relationship with the prevalence of IR (p = 0.007, p = 0.025, separately). The Receiver operating characteristic (ROC) curve demonstrated that the areas under the curve (AUC) for NLR, MLR, PLR, CRP, SAA and SOD in predicting occurrence of IR in T2DM patients were 0.603, 0.575, 0.581, 0.644, 0.594 and 0.632 respectively, with sensitivity of 79.5%, 95.2%, 46.9%,54.1% (or 51.4), 47.6% (or 45.7%) and 98.6% and specificity of 37.2%, 19.5%, 69.9%, 69% (or 71.7%), 71.6% (or 73.5%) and 23% respectively.

Conclusion

Our findings support the notion that higher magnitude of NLR, PLR, MLR, CRP, and SAA values, corresponded to lower SOD levels, indicating a more severe degree of IR in T2DM patients. Additionally, NLR, PLR, MLR, CRP, SAA, and SOD demonstrated predictive potential for assessing IR. Regrettably, due to the retrospective nature of this study, it was not feasible to take a measurement the majority of inflammatory factors and reactive oxygen species (ROS).
Literature
1.
go back to reference Muzica CM, Sfarti C, Trifan A et al. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. Can J Gastroenterol Hepatol. 2020; 2020: 6638306–6638310. Muzica CM, Sfarti C, Trifan A et al. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. Can J Gastroenterol Hepatol. 2020; 2020: 6638306–6638310.
2.
go back to reference Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas,9th edition. Diabetes Res Clin Pract. 2019;157:107843–52.PubMedCrossRef Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas,9th edition. Diabetes Res Clin Pract. 2019;157:107843–52.PubMedCrossRef
4.
go back to reference Li Y, Zhao H, Guo Y, et al. Association of preadmission metformin use and prognosis in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2021;12(9):811776–83.CrossRef Li Y, Zhao H, Guo Y, et al. Association of preadmission metformin use and prognosis in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2021;12(9):811776–83.CrossRef
5.
go back to reference Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus type 2 diabetes. Diabetes Metab Syndr. 2019;13:1165–72.PubMedCrossRef Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus type 2 diabetes. Diabetes Metab Syndr. 2019;13:1165–72.PubMedCrossRef
6.
go back to reference Yashiro M, Furukawa H, Asano T, et al. Serum amyloid A1(SAA1) gene polymorphisms in Japanese patients with adult onset still’s disease. Medicine. 2018;97(49):13394–8.CrossRef Yashiro M, Furukawa H, Asano T, et al. Serum amyloid A1(SAA1) gene polymorphisms in Japanese patients with adult onset still’s disease. Medicine. 2018;97(49):13394–8.CrossRef
7.
go back to reference Liu T, Li M, Cui CY, et al. Association between serum amyloid A levels and type 2 diabetes Mellitus: a systematic review and Meta-analysis. Endocrinol Metab. 2023;38:315–27.CrossRef Liu T, Li M, Cui CY, et al. Association between serum amyloid A levels and type 2 diabetes Mellitus: a systematic review and Meta-analysis. Endocrinol Metab. 2023;38:315–27.CrossRef
8.
go back to reference Turovsky EA. Deregulation of ca(2+) -signaling systems in white adipocytes, manifested as the loss of rhythmic activity, underlies the development of multiple hormonal resistance at obesity and type 2 diabetes. Endocrinol Diabetes Metab. 2021;22(10):1113–9. Turovsky EA. Deregulation of ca(2+) -signaling systems in white adipocytes, manifested as the loss of rhythmic activity, underlies the development of multiple hormonal resistance at obesity and type 2 diabetes. Endocrinol Diabetes Metab. 2021;22(10):1113–9.
9.
go back to reference Van Hove L, Kim KR, Arrick DM, et al. A cannabinoid type 2(CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes. Nat Med. 2021;133(11):104077–92. Van Hove L, Kim KR, Arrick DM, et al. A cannabinoid type 2(CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes. Nat Med. 2021;133(11):104077–92.
10.
go back to reference Wu CS, Lin CC, Hsieh FC et al. Antiobesity Effect of Lacticaseibacillus paracasei LM-141 on High-Fat Diet-Induced Rats through Alleviation of Inflammation and Insulin Resistance. Evid Based Complement Alternat Med. 2023; 2023: 1011591–1011604. Wu CS, Lin CC, Hsieh FC et al. Antiobesity Effect of Lacticaseibacillus paracasei LM-141 on High-Fat Diet-Induced Rats through Alleviation of Inflammation and Insulin Resistance. Evid Based Complement Alternat Med. 2023; 2023: 1011591–1011604.
11.
go back to reference Shiny A, Bibin YS, Shanthirani CS, et al. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. Diabetes Technol Ther. 2014;16:524–30.PubMedCrossRef Shiny A, Bibin YS, Shanthirani CS, et al. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. Diabetes Technol Ther. 2014;16:524–30.PubMedCrossRef
12.
go back to reference Li L, Shen Q, Rao SJ. Association of Neutrophil-to-Lymphocyte Ratio and platelet-to-lymphocyte ratio with Diabetic kidney disease in Chinese patients with type 2 diabetes: a cross-sectional study. Ther Clin Risk Manag. 2022;18:1157–66.PubMedPubMedCentralCrossRef Li L, Shen Q, Rao SJ. Association of Neutrophil-to-Lymphocyte Ratio and platelet-to-lymphocyte ratio with Diabetic kidney disease in Chinese patients with type 2 diabetes: a cross-sectional study. Ther Clin Risk Manag. 2022;18:1157–66.PubMedPubMedCentralCrossRef
13.
go back to reference Wen HJ, Yu H. Correlation analysis of carotid plaque in young patients with newly diagnosed type 2 diabetes and platelet-to-lymphocyte ratio and neutrophil- lymphocyte ratio. Vascular. 2023;31:90–7.PubMedCrossRef Wen HJ, Yu H. Correlation analysis of carotid plaque in young patients with newly diagnosed type 2 diabetes and platelet-to-lymphocyte ratio and neutrophil- lymphocyte ratio. Vascular. 2023;31:90–7.PubMedCrossRef
14.
go back to reference Joshi A, Bhambhani A, Barure B, et al. Neutrophil-lymphocyte ratio and platelet lymphocyte ratio as markers of stable ischemic heart disease in diabetic patients. Medicine. 2023;102:32735–32710.CrossRef Joshi A, Bhambhani A, Barure B, et al. Neutrophil-lymphocyte ratio and platelet lymphocyte ratio as markers of stable ischemic heart disease in diabetic patients. Medicine. 2023;102:32735–32710.CrossRef
15.
go back to reference Zeng J, Chen M, Feng Q, et al. The platelet-to-lymphocyte ratio predicts Diabetic Retinopathy in type 2 diabetes Mellitus. Diabetes Metab Syndr Obes. 2022;15:3617–26.PubMedPubMedCentralCrossRef Zeng J, Chen M, Feng Q, et al. The platelet-to-lymphocyte ratio predicts Diabetic Retinopathy in type 2 diabetes Mellitus. Diabetes Metab Syndr Obes. 2022;15:3617–26.PubMedPubMedCentralCrossRef
16.
go back to reference Manjoo P, Dannenbaum D, Joseph L, et al. Utility of current obesity thresholds in signaling diabetes risk in the James Bay Cree of Eeyou Istchee.BMJ Open. Diabetes Res Care. 2015;3:114–21. Manjoo P, Dannenbaum D, Joseph L, et al. Utility of current obesity thresholds in signaling diabetes risk in the James Bay Cree of Eeyou Istchee.BMJ Open. Diabetes Res Care. 2015;3:114–21.
17.
go back to reference Tabák AG, Kivimäki M, Brunner EJ, et al. Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study. Eur J Endocrinol. 2010;163:89–95.PubMedCrossRef Tabák AG, Kivimäki M, Brunner EJ, et al. Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study. Eur J Endocrinol. 2010;163:89–95.PubMedCrossRef
18.
go back to reference Bhutta H, Agha R, Wong J, et al. Neutrophil lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a crosssectional study. Vasc Endovascular Surg. 2011;45:227–31.PubMedCrossRef Bhutta H, Agha R, Wong J, et al. Neutrophil lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a crosssectional study. Vasc Endovascular Surg. 2011;45:227–31.PubMedCrossRef
19.
go back to reference Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro-and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care. 2004;27:216–22.PubMedCrossRef Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro-and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care. 2004;27:216–22.PubMedCrossRef
20.
go back to reference Chung KP, Chang HT, Lo SC, et al. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock. 2015;43:569–75.PubMedCrossRef Chung KP, Chang HT, Lo SC, et al. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock. 2015;43:569–75.PubMedCrossRef
21.
go back to reference Fonseka TM, McIntyre RS, Soczynska JK, et al. Novel investigational drugs targeting IL-6 signaling for the treatment of depression. Expert Opin Investig Drugs. 2015;24:459–75.PubMedCrossRef Fonseka TM, McIntyre RS, Soczynska JK, et al. Novel investigational drugs targeting IL-6 signaling for the treatment of depression. Expert Opin Investig Drugs. 2015;24:459–75.PubMedCrossRef
22.
go back to reference Buyukkaya E, Karakas MF, Karakas E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2014;20:159–63.PubMedCrossRef Buyukkaya E, Karakas MF, Karakas E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2014;20:159–63.PubMedCrossRef
23.
go back to reference Duman TT, Aktas G, Atak BM, et al. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19:1602–6.PubMedPubMedCentralCrossRef Duman TT, Aktas G, Atak BM, et al. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19:1602–6.PubMedPubMedCentralCrossRef
24.
go back to reference Lou MQ, Luo P, Tang R, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15:9–14.PubMedPubMedCentralCrossRef Lou MQ, Luo P, Tang R, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15:9–14.PubMedPubMedCentralCrossRef
25.
go back to reference Gong S, Gao X, Xu F, et al. Association of lymphocyte to monocyte ratio with severity of coronary artery disease. Medicine. 2018;97:12813–8.CrossRef Gong S, Gao X, Xu F, et al. Association of lymphocyte to monocyte ratio with severity of coronary artery disease. Medicine. 2018;97:12813–8.CrossRef
26.
go back to reference Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23:87–104.PubMedPubMedCentralCrossRef Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23:87–104.PubMedPubMedCentralCrossRef
27.
go back to reference Kocak MZ, Aktas G, Duman TT, et al. Monocyte lymphocyte ratio as a predictor of Diabetic kidney Injury in type 2 diabetes mellitus; the MADKID Study. J Diabetes Metab Disord. 2020;19:997–1002.PubMedPubMedCentralCrossRef Kocak MZ, Aktas G, Duman TT, et al. Monocyte lymphocyte ratio as a predictor of Diabetic kidney Injury in type 2 diabetes mellitus; the MADKID Study. J Diabetes Metab Disord. 2020;19:997–1002.PubMedPubMedCentralCrossRef
28.
go back to reference Yue S, Zhang J, Wu J, et al. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12:10009–19.PubMedPubMedCentralCrossRef Yue S, Zhang J, Wu J, et al. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12:10009–19.PubMedPubMedCentralCrossRef
29.
go back to reference Repsold L, Joubert AM. Platelet function, role in thrombosis, inflammation, and consequences in chronic myeloproliferative disorders. Cells. 2021;10:3034–48.PubMedPubMedCentralCrossRef Repsold L, Joubert AM. Platelet function, role in thrombosis, inflammation, and consequences in chronic myeloproliferative disorders. Cells. 2021;10:3034–48.PubMedPubMedCentralCrossRef
30.
go back to reference Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018;17:121–37.PubMedPubMedCentralCrossRef Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018;17:121–37.PubMedPubMedCentralCrossRef
31.
go back to reference Adaikalakoteswari A, Rema M, Mohan V, et al. Oxidative DNA damage and augmentation of poly (ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. Int J Biochem Cell Biol. 2007;39:1673–84.PubMedCrossRef Adaikalakoteswari A, Rema M, Mohan V, et al. Oxidative DNA damage and augmentation of poly (ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. Int J Biochem Cell Biol. 2007;39:1673–84.PubMedCrossRef
32.
go back to reference Zhang KX, Ding S, Lyu XY, et al. Correlation between the platelet-to-lymphocyte ratio and diabetic foot ulcer in patients with type 2 diabetes mellitus. J Clin Lab Anal. 2021;35:23719–24.CrossRef Zhang KX, Ding S, Lyu XY, et al. Correlation between the platelet-to-lymphocyte ratio and diabetic foot ulcer in patients with type 2 diabetes mellitus. J Clin Lab Anal. 2021;35:23719–24.CrossRef
33.
go back to reference Wascher TC. Endothelial transport processes and tissue metabolism: evidence for microvascular endothelial dysfunction in insulin- resistant diseases? Eur J Clin Investig. 2015;27:831–5.CrossRef Wascher TC. Endothelial transport processes and tissue metabolism: evidence for microvascular endothelial dysfunction in insulin- resistant diseases? Eur J Clin Investig. 2015;27:831–5.CrossRef
34.
go back to reference Zhang Y, Zhang J, Sheng H, et al. Acute phase reactant serum amyloid A in inflammation and other diseases. Adv Clin Chem. 2019;90:25–80.PubMedCrossRef Zhang Y, Zhang J, Sheng H, et al. Acute phase reactant serum amyloid A in inflammation and other diseases. Adv Clin Chem. 2019;90:25–80.PubMedCrossRef
35.
go back to reference Zhao Y, He X, Shi X, et al. Association between serum amyloid A and obesity: a meta-analysis and systematic review. Inflamm Res. 2010;59:323–34.PubMedCrossRef Zhao Y, He X, Shi X, et al. Association between serum amyloid A and obesity: a meta-analysis and systematic review. Inflamm Res. 2010;59:323–34.PubMedCrossRef
36.
go back to reference Engin A. The pathogenesis of obesity-associated adipose tissue inflammation. Adv Exp Med Biol. 2017;960:221–45.PubMedCrossRef Engin A. The pathogenesis of obesity-associated adipose tissue inflammation. Adv Exp Med Biol. 2017;960:221–45.PubMedCrossRef
37.
go back to reference Venkat P, Gao H, Findeis EL, et al. Therapeutic effects of CD133 + exosomes on liver function after stroke in type 2 diabetic mice. Front Neurosci. 2023;17:1–11.CrossRef Venkat P, Gao H, Findeis EL, et al. Therapeutic effects of CD133 + exosomes on liver function after stroke in type 2 diabetic mice. Front Neurosci. 2023;17:1–11.CrossRef
38.
40.
go back to reference Coballase-Urrutia E, Navarro L, Ortiz JL, et al. Static magnetic fields modulate the response of different oxidative stress markers in a restraint stress model animal. Biomed Res Int. 2018;2018:3960408–16.PubMedPubMedCentralCrossRef Coballase-Urrutia E, Navarro L, Ortiz JL, et al. Static magnetic fields modulate the response of different oxidative stress markers in a restraint stress model animal. Biomed Res Int. 2018;2018:3960408–16.PubMedPubMedCentralCrossRef
41.
go back to reference Liu J, Zhang YJ, Shi DR, et al. Vitamin D alleviates type 2 diabetes Mellitus by mitigating oxidative stress-Induced pancreatic β-Cell impairment. Exp Clin Endocrinol Diabetes. 2023;131:656–66.PubMedPubMedCentralCrossRef Liu J, Zhang YJ, Shi DR, et al. Vitamin D alleviates type 2 diabetes Mellitus by mitigating oxidative stress-Induced pancreatic β-Cell impairment. Exp Clin Endocrinol Diabetes. 2023;131:656–66.PubMedPubMedCentralCrossRef
42.
go back to reference Zhang G, Wang HF. Correlation between inflammatory-oxidative stress level in peripheral blood and insulin resistance in diabetic patients. Hebei Med J. 2023;45(7):1050–3. Zhang G, Wang HF. Correlation between inflammatory-oxidative stress level in peripheral blood and insulin resistance in diabetic patients. Hebei Med J. 2023;45(7):1050–3.
44.
go back to reference Duffy BK, Gurm HS, Rajagopal V, et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993–6.PubMedCrossRef Duffy BK, Gurm HS, Rajagopal V, et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993–6.PubMedCrossRef
45.
go back to reference Liu ZS. Efficacy of metformin combined with liraglutide on the glucose and lipid metabolism, vascular endothelial function, and oxidative stress of patients with T2DM and metabolic syndrome. Pak J Med Sci. 2024;40(1):26–30.PubMedPubMedCentral Liu ZS. Efficacy of metformin combined with liraglutide on the glucose and lipid metabolism, vascular endothelial function, and oxidative stress of patients with T2DM and metabolic syndrome. Pak J Med Sci. 2024;40(1):26–30.PubMedPubMedCentral
46.
go back to reference Nalini M, Raghavulu BV, Annapurna A, et al. Correlation of various serum biomarkers with the severity of diabetic retinopathy. Diabetes Metab Syndr. 2017;11:451–154.CrossRef Nalini M, Raghavulu BV, Annapurna A, et al. Correlation of various serum biomarkers with the severity of diabetic retinopathy. Diabetes Metab Syndr. 2017;11:451–154.CrossRef
47.
go back to reference Kahraman C, Kahraman NK, Aras B et al. The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot study. Arch Med Sci 2016; 12: 571-575. Kahraman C, Kahraman NK, Aras B et al. The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot study. Arch Med Sci 2016; 12: 571-575.
Metadata
Title
Correlation between insulin resistance and the rate of neutrophils-lymphocytes, monocytes-lymphocytes, platelets-lymphocytes in type 2 diabetic patients
Authors
Yuanyuan Zhang
Huaizhen Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01564-x

Other articles of this Issue 1/2024

BMC Endocrine Disorders 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.